420 related articles for article (PubMed ID: 22257057)
21. Reversing Multidrug Resistance in Chemo-resistant Human Lung Adenocarcinoma (A549/DOX) Cells by Algerian Propolis Through Direct Inhibiting the P-gp Efflux-pump, G0/G1 Cell Cycle Arrest and Apoptosis Induction.
Kebsa W; Lahouel M; Rouibah H; Zihlif M; Ahram M; Abu-Irmaileh B; Mustafa E; Al-Ameer HJ; Al Shhab M
Anticancer Agents Med Chem; 2018; 18(9):1330-1337. PubMed ID: 30088453
[TBL] [Abstract][Full Text] [Related]
22. Reversal of multidrug resitance by natural substances from plants.
Molnár J; Engi H; Hohmann J; Molnár P; Deli J; Wesolowska O; Michalak K; Wang Q
Curr Top Med Chem; 2010; 10(17):1757-68. PubMed ID: 20645919
[TBL] [Abstract][Full Text] [Related]
23. Targeted inhibitors of P-glycoprotein increase chemotherapeutic-induced mortality of multidrug resistant tumor cells.
Nanayakkara AK; Follit CA; Chen G; Williams NS; Vogel PD; Wise JG
Sci Rep; 2018 Jan; 8(1):967. PubMed ID: 29343829
[TBL] [Abstract][Full Text] [Related]
24. Recent advances in the search of BCRP- and dual P-gp/BCRP-based multidrug resistance modulators.
Dei S; Braconi L; Romanelli MN; Teodori E
Cancer Drug Resist; 2019; 2(3):710-743. PubMed ID: 35582565
[TBL] [Abstract][Full Text] [Related]
25. P-glycoprotein--implications of metabolism of neoplastic cells and cancer therapy.
Breier A; Barancík M; Sulová Z; Uhrík B
Curr Cancer Drug Targets; 2005 Sep; 5(6):457-68. PubMed ID: 16178819
[TBL] [Abstract][Full Text] [Related]
26. P-glycoprotein inhibition as a therapeutic approach for overcoming multidrug resistance in cancer: current status and future perspectives.
Binkhathlan Z; Lavasanifar A
Curr Cancer Drug Targets; 2013 Mar; 13(3):326-46. PubMed ID: 23369096
[TBL] [Abstract][Full Text] [Related]
27. Potential of Natural-Based Anticancer Compounds for P-Glycoprotein Inhibition.
Dinić J; Podolski-Renić A; Jeremić M; Pešić M
Curr Pharm Des; 2018; 24(36):4334-4354. PubMed ID: 30648503
[TBL] [Abstract][Full Text] [Related]
28. 5-Oxo-hexahydroquinoline derivatives as modulators of P-gp, MRP1 and BCRP transporters to overcome multidrug resistance in cancer cells.
Ranjbar S; Khonkarn R; Moreno A; Baubichon-Cortay H; Miri R; Khoshneviszadeh M; Saso L; Edraki N; Falson P; Firuzi O
Toxicol Appl Pharmacol; 2019 Jan; 362():136-149. PubMed ID: 30391378
[TBL] [Abstract][Full Text] [Related]
29. Modulation of function of three ABC drug transporters, P-glycoprotein (ABCB1), mitoxantrone resistance protein (ABCG2) and multidrug resistance protein 1 (ABCC1) by tetrahydrocurcumin, a major metabolite of curcumin.
Limtrakul P; Chearwae W; Shukla S; Phisalphong C; Ambudkar SV
Mol Cell Biochem; 2007 Feb; 296(1-2):85-95. PubMed ID: 16960658
[TBL] [Abstract][Full Text] [Related]
30. Overcoming tumor multidrug resistance using drugs able to evade P-glycoprotein or to exploit its expression.
Nobili S; Landini I; Mazzei T; Mini E
Med Res Rev; 2012 Nov; 32(6):1220-62. PubMed ID: 21374643
[TBL] [Abstract][Full Text] [Related]
31. Reversal of P-glycoprotein mediated multidrug resistance in K562 cell line by a novel synthetic calmodulin inhibitor, E6.
Zhu HJ; Wang JS; Guo QL; Jiang Y; Liu GQ
Biol Pharm Bull; 2005 Oct; 28(10):1974-8. PubMed ID: 16204958
[TBL] [Abstract][Full Text] [Related]
32. Phytochemicals reverse P-glycoprotein mediated multidrug resistance via signal transduction pathways.
Ganesan M; Kanimozhi G; Pradhapsingh B; Khan HA; Alhomida AS; Ekhzaimy A; Brindha GR; Prasad NR
Biomed Pharmacother; 2021 Jul; 139():111632. PubMed ID: 34243600
[TBL] [Abstract][Full Text] [Related]
33. Targeting P-Glycoprotein: Nelfinavir Reverses Adriamycin Resistance in K562/ADR Cells.
Liu W; Meng Q; Sun Y; Wang C; Huo X; Liu Z; Sun P; Sun H; Ma X; Liu K
Cell Physiol Biochem; 2018; 51(4):1616-1631. PubMed ID: 30497065
[TBL] [Abstract][Full Text] [Related]
34. Natural Products as Alternative Choices for P-Glycoprotein (P-gp) Inhibition.
Dewanjee S; Dua TK; Bhattacharjee N; Das A; Gangopadhyay M; Khanra R; Joardar S; Riaz M; Feo V; Zia-Ul-Haq M
Molecules; 2017 May; 22(6):. PubMed ID: 28587082
[TBL] [Abstract][Full Text] [Related]
35. Design, synthesis, and discovery of ocotillol-type amide derivatives as orally available modulators of P-glycoprotein-mediated multidrug resistance.
Ren Q; Yang G; Guo M; Guo J; Li Y; Lu J; Yang Q; Tang H; Li Y; Fang X; Sun Y; Qi JG; Tian J; Wang H
Eur J Med Chem; 2019 Jan; 161():118-130. PubMed ID: 30347326
[TBL] [Abstract][Full Text] [Related]
36. Multidrug resistance (MDR) in cancer. Mechanisms, reversal using modulators of MDR and the role of MDR modulators in influencing the pharmacokinetics of anticancer drugs.
Krishna R; Mayer LD
Eur J Pharm Sci; 2000 Oct; 11(4):265-83. PubMed ID: 11033070
[TBL] [Abstract][Full Text] [Related]
37. Flavonoids as P-gp Inhibitors: A Systematic Review of SARs.
Cui J; Liu X; Chow LMC
Curr Med Chem; 2019; 26(25):4799-4831. PubMed ID: 30277144
[TBL] [Abstract][Full Text] [Related]
38. Design, synthesis and evaluation of a novel series of inhibitors reversing P-glycoprotein-mediated multidrug resistance.
Ghaleb H; Li H; Kairuki M; Qiu Q; Bi X; Liu C; Liao C; Li J; Hezam K; Huang W; Qian H
Chem Biol Drug Des; 2018 Sep; 92(3):1708-1716. PubMed ID: 29786944
[TBL] [Abstract][Full Text] [Related]
39. Discovery of traditional Chinese medicine monomers and their synthetic intermediates, analogs or derivatives for battling P-gp-mediated multi-drug resistance.
Ma X; Hu M; Wang H; Li J
Eur J Med Chem; 2018 Nov; 159():381-392. PubMed ID: 30308411
[TBL] [Abstract][Full Text] [Related]
40. Bipiperidinyl derivatives of 23-hydroxybetulinic acid reverse resistance of HepG2/ADM and MCF-7/ADR cells.
Zhang DM; Li YJ; Shu C; Ruan ZX; Chen WM; Yiu A; Peng YH; Wang J; Lan P; Yao Z; Fung KP; Fu LW; Chen ZS; Ye WC
Anticancer Drugs; 2013 Jun; 24(5):441-54. PubMed ID: 23466650
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
